FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/06/2026
Voltar para busca
Dado oficial do USPTO
NEXA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
51
Atualização mais recente
30/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10
Data de depósito
23/12/2022
Data de registro
31/03/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/03/2026
Última transação
30/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
83
Localização do titular
AU
Examinador
BROWN, TINA
Unidade examinadora
M90
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Cochlear Limited
Representantes
WILLIAM M. BRYNER KILPATRICK TOWNSEND & STOCKTON LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the diagnosistreatmentmanagement or amelioration of inner ear or auditory system deficiencies; medical preparations for the diagnosistreatmentmanagement or amelioration of inner ear or auditory system deficiencies; pharmaceutical drugspharmaceutical preparations for the diagnosistreatmentmanagement or amelioration of inner ear or auditory system deficiencies; corticosteroids; steroidsdexamethasone; anti-inflammatory drugs; chemical reagents for medical purposes; chemical preparations for medical purposesfor the diagnosistreatmentmanagement or amelioration of inner ear or auditory system deficiencies; all the foregoing for or in relation to the inner ear or auditory system of a human; none of the foregoing for use in laboratory-testing or medical-transport applicationspackaged or sold primarily in connection with vialstest tubessyringesnon-implantable cartridgesnon-implantable medical fluid containers for such applications
Classe 9
Downloadable and recorded software for managing clinical data; computer softwarerecorded for data analysisdatabases managementmanaging data for use in the diagnosistreatmentmanagement or amelioration of inner ear or auditory system deficiencies; downloadable computer programs for data analysisdatabases managementmanaging data for use in the diagnosistreatmentmanagement or amelioration of inner ear or auditory system deficiencies; computer software applicationsdownloadable for data analysisdatabases managementmanaging data for use in the diagnosistreatmentmanagement or amelioration of inner ear or auditory system deficiencies; all the foregoing for use in the diagnosistreatmentmanagement or amelioration of inner ear or auditory system deficiencies; none of the foregoing in the field of digital imaging or digital image processinganalysismeasurementdisplay comparison or simulation of effects of surgical or product treatment outcomes
Classe 10
Medical deviceshearing aidscochlear implants made from artificial materials and in-ear monitors for medical purposescomponents of medical devicessound processors and cochlear implants made from artificial materials adapted for use with prosthetic hearing devices; prosthetic hearing devices and components of prosthetic hearing deviceshearing aidssound processors and cochlear implants made from artificial materials adapted for use with prosthetic hearing devices; accessories for use with prosthetic hearing deviceswireless transmitters and receivers for use with hearing aids; medical implantsan implanted hearing device in the nature of a cochlear implant made from artificial materialsfor delivering pharmaceutical preparationsmedical preparationspharmaceutical drugscorticosteroidsdexamethasoneanti-inflammatory drugschemical reagentschemical preparations to the inner ear or auditory system of a human; none of the foregoing for laboratory-testing or medical-transport usesnone of the foregoing non-implantable fluid-delivery containerscartridgessyringesvialstest tubes sold for such uses
Publicações
Histórico de despachos e eventos da marca no USPTO.
51 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/05/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
31/03/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
31/03/2026
TMBN
TTAB RELEASE CASE TO TRADEMARKS
10/03/2026
OP.T
OPPOSITION TERMINATED NO. 999999
10/03/2026
OP.D
OPPOSITION DISMISSED NO. 999999
10/03/2026
RFNT
REFUSAL PROCESSED BY IB
17/01/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
17/12/2024
OP.I
OPPOSITION INSTITUTED NO. 999999
16/12/2024
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
16/12/2024
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
15/12/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/10/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/09/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
27/09/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/09/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/09/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27/09/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
27/09/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/09/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
25/09/2024
GPNX
NOTIFICATION PROCESSED BY IB
01/07/2024
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
25/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/06/2024
PUBO
PUBLISHED FOR OPPOSITION
18/06/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/06/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/06/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/05/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
14/05/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
14/05/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
14/05/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
14/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/05/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/05/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
20/04/2024
GNFR
FINAL REFUSAL E-MAILED
20/04/2024
CNFR
FINAL REFUSAL WRITTEN
20/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/04/2024
RFNT
REFUSAL PROCESSED BY IB
01/11/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/10/2023
RFRR
REFUSAL PROCESSED BY MPU
06/10/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
27/09/2023
CNRT
NON-FINAL ACTION WRITTEN
26/09/2023
DOCK
ASSIGNED TO EXAMINER
24/09/2023
MAFR
APPLICATION FILING RECEIPT MAILED
02/05/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/04/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
27/04/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NEXA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.